3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Colorectal Neoplasms
3
Breast Neoplasms
3
Stomach Neoplasms
2
Pancreatic Neoplasms
2
Multiple Myeloma
2
Carcinoma, Non-Small-Cell Lung
2
Tongue Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Tubular Adenocarcinoma
1
Neoplasms
1
Neoplasm Metastasis
1
Lymphoma, Large B-Cell, Diffuse
1
Infections
1
Hemangioma, Cavernous, Central Nervous System
1
Hemangioma
1
Head and Neck Neoplasms
1
Gallbladder Neoplasms
1
Gallbladder Cancer Unresectable
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Cancer-Related Condition
1
Cachexia
1
Brenner Tumor
1
Biliary Tract Neoplasms
1
Arthritis, Rheumatoid
1
Interventions
Radiotherapy
4
Magnetic Resonance Spectroscopy
2
Fluorodeoxyglucose F18
2
Docetaxel
2
Cisplatin
2
fluoromisonidazole
1
aldesleukin
1
X-Rays
1
Rubidium-82
1
Ritonavir
1
Psychiatric Rehabilitation
1
Observation
1
Neoadjuvant Therapy
1
Luteolin
1
Indinavir
1
Glossectomy
1
Fluorouracil
1
Erlotinib Hydrochloride
1
DMAC2L protein, human
1
Chemotherapy, Adjuvant
1
Celecoxib
1
Anesthesia, Intravenous
1
5-fluoropentyl-2-methylmalonic acid
1
26S proteasome non-ATPase regulatory subunit 13
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Tongue Neoplasms
×
Observation
×
Clear all
NCT02748707
2022-04-28
ERLO-XIB
Tata Memorial Hospital
Phase 2
Unknown
64 enrolled